A safety and efficacy study of autologous bone marrow cell transplantation for cirrhosis of liver caused by lifestyle related disease - ABMi therapy for liver cirrhosis(lifestyle related disease )

Heart life hospital0 sites10 target enrollmentOctober 1, 2014

Overview

Phase: 未知
Intervention: Not specified
Conditions: Cirrhosis of liver caused by lifestyle related disease(Including NASH)
Sponsor: Heart life hospital
Enrollment: 10
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

October 1, 2014

End Date

January 29, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Heart life hospital

•1\) Hepatocellular carcinoma (HCC), except for cases having been treated completely without history of recurrence 2\) Maligi1ant tumor other than HCC 3\) Total bilirubin under 3mg/dL 4\) Hemoglobin under 8g/dl or Platelets under 50000/ul at the registration 5\) Esophageal or gastric varices with a risk of bursting, except for cases only with cured history of such conditions 6\) Renal dysfunction with 2mg/dl or higher serum creatinine 7\) Less than six months after abstaining from alcoholic in alcoholic cirrhosis. 8\) Cases that cannot obtain the informed consent to autologous blood transfusion 9\) Pregnancy 10\)Performance Status 3 or 4 11\) Not fit for general anesthesia 12\) Other conditions that doctor considered not suitable for this study